Xact Labs awarded patent for genetic data integration

Created at 1 Jun · 4:10 PM1 source↑ Market-relevant

IN SHORT

Xact Labs has been granted U.S. Patent No. 12,640,242, focusing on integrating genetic data for precision medicine. This patent aims to enhance large-scale integration across healthcare technology, pharmacy, and payer markets.

Key Numbers

12,640,242U.S. Patent number

Who's Involved

Xact Labs

Company awarded U.S. Patent No. 12,640,242

U.S. Patent and Trademark Office

Issuing authority for the patent

↳ Why This Matters

The issuance of this patent signifies a development in Xact Labs' efforts to build infrastructure for precision medicine. The technology aims to streamline the integration of genetic data, which is crucial for personalized treatment approaches in healthcare.

Key facts

Xact Labs has been issued U.S. Patent No. 12,640,242.
The patent relates to genetic data integration for precision medicine.
The technology is designed for integration across healthcare technology, pharmacy, and payer markets.

FREQUENTLY ASKED

The patent is for Xact Labs' technology related to the integration of genetic data for precision medication infrastructure.

Xact Labs targets healthcare technology, pharmacy, and payer markets for large-scale integration.

The patent was issued on May 26, 2026.

What Happens Next

01Xact Labs will likely focus on commercializing and integrating the patented technology into healthcare systems.

Xact Labs awarded patent for genetic data integration

PiQ Daily

Key facts

Xact Labs awarded patent for genetic data integration

PiQ Daily

Key facts

Get the newsletter.